Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Immunovant Q1 EPS $(0.31) Misses $(0.30) Estimate

Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.30) by 3.33 percent. This is a 18.42 percent increase over losses of $(0.38) per share from the

byLuke J Jacobi

August 9, 2021

1 minute read

Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.30) by 3.33 percent. This is a 18.42 percent increase over losses of $(0.38) per share from the same period last year.